MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors
Jayavarshni Ganesan(Inserm), Stefan Engelhardt(Heidelberg University), Thomas Thum(Medizinische Hochschule Hannover), Xavier Loyer(Inserm), Mauro Giacca(King's College London), Claudia Jentzsch(Technical University of Munich), Yassine Sassi(Inserm), Bernhard Laggerbauer(Inserm), Andrea Ahles(Inserm), Simon Leierseder(Inserm), Deepak Ramanujam(Technical University of Munich), Lorena Zentilin(National Center for Genetic Engineering and Biotechnology), Stanislas Werfel(Technical University of Munich)
Cited by 242
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767